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Endovascular repair is an established modality of treatment for abdominal aortic aneurysms. It is therefore
reasonable to expect its application to other less common aneurysmal conditions, including isolated iliac and
popliteal artery aneurysms (PAA). There are, however, essential differences between aortic aneurysms and peripheral
aneurysms: smaller arterial caliber, mobility of the arterial segment, associated occlusive disease, and devices that
have not been specifically designed for peripheral applications. Due to these differences, results obtained in
abdominal aortic aneurysms cannot be extrapolated to peripheral aneurysms. The attraction of the endovascular
repair for PAA is its minimally invasive nature. The literature, however, provides only case reports, case series and
small cohorts, and one small randomized, controlled trial. A cumulative summary of these studies provides the
clinician with information upon which to base the choice of treatment on a specific patient. Endovascular repair for
PAA with suitable anatomy and good run-off can be considered safe, and medium term results appear comparable
with those of open repair. ( J Vasc Surg 2010;51:1056-60.)Popliteal artery aneurysms (PAA) are the most com-
mon peripheral aneurysms (70%-85%). In asymptomatic
patients treated conservatively, overall pooled estimates of
complications and onset of new symptoms is 41.6% (95%
confidence interval [CI], 35.6% to 45.6%)1 over a period of
three to five years. In addition, survival at 10 years in
patients with PAA is reduced (35%) compared with a
matched population (62%).
Pooled estimates of five-year patency for open repair is
72% (95%CI, 71% to 73%); mortality 0%-2%; complications
include amputation (3.2%), occlusion of the graft (3.9%),
wound infection (4.7%), foot drop (1.3%), deep venous
thrombosis (1.6%), hematoma (3.4%).1 The first case of
PAA treated with endovascular repair was reported in 1994.
PAAs are typically limited arterial lesions for which endo-
vascular repair may offer an ideal solution; however, the
evidence from the literature is still scant, with small studies
and short follow up. Recognizing that stent technology is
also in evolution, we will summarize the current status of
endovascular repair for PAA.
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1056METHODS
The Medline and EMBASE databases were searched
from 1994 (the first reported case) to June 2009, using
OVID software and a comprehensive search strategy. All
studies reporting the outcome patency were included. Pri-
mary and secondary patentcy rates were the outcomes of
interest.
Statistical analysis
Only one randomized, controlled trial and three cohort
studies, comparing results between open and endovascular
repair, were found. Results were summarized comparing
the endovascular group with the open group using odds
ratios, with an odds ratio of1 denoting that an event (ie,
occlusion) was more common following endovascular sur-
gery. All the remaining studies were case reports, cases
series, and cohort studies of endovascular repair alone. For
these studies, results were summarized, without compari-
son with the open group, using the generic inverse variance
function of Review Manager, which requires the treatment
effect and the standard error of mean for each of the studies
included (ReviewManager, Version 4.2, Cochrane Collab-
oration). When a zero value in one cell affected computa-
tion, the Haldane correction was applied, replacing the
zero value with 0.5.2
In view of the heterogeneity of the cohort of patients
included (symptomatic vs asymptomatic; poor run-off vs
good run-off; different types of stent used for endovascular
repair and different types of conduits used for open repair),
results were summarized using random effects models and
95% confidence intervals.
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Overall, 320 patients receiving an endovascular interven-
tion were available for analysis,1,3-33 while comparison of the
endovascular versus the open interventionwas available for 43
and 116 patients, respectively.3,4,24,30 The average diameter
for which an aneurysm was treated was 32 mm  1 mm
(range, 12 mm-69 mm).3,5,7-15,20,24,26-28,31-37 In the ma-
jority of patients, the endovascular repair was done in the
presence of a good tibial run-off; at least two patent tibial
arteries were present in 71% (95% CI 65%-76%) of pa-
tients.1,7,10,12-15,24,27,32,33,35,38
Several types of stents have been used to treat PAA. At
the beginning of the era of this new modality of treatment,
in North America home-made devices made of balloon
expandable stents covered with vein or PTFE were used,
while in Europe the Cragg Endo Pro stents were used,
which included the System 1 (a self expandable nitinol stent
covered by polyester fabric, Cragg EndoPro System; Min-
tec, La Ciotat, France); the Passager stent graft (a self
expandable, polyester-covered metal stent-grafts; Boston
Scientific, Watertown, Mass), and the Corvita stentgraft (a
metallic self-expandable, braided wire stent to which is
bonded an inner liner of polycarbonate urethane microfi-
bers; Boston Scientific, Bülach, Switzerland). Later on, the
more flexible Wallstent-PTFE (Boston Scientific, Target
Therapeutics, Fremont, Calif) and the Wallgraft (a self-
expanding, polyester-covered stent-graft) appear to im-
prove on their predecessors. In the more modern era, most
repairs have been made using the Hemobahn/Viabahn
stent grafts (a PTFE-lined exoskeleton made of a continu-
ous filament of nitinol; W. L. Gore & Associates, Flagstaff,
Ariz). The Anaconda limbs (Vascutek, Renfrewshire, Scot-
land) have also been used, although the experience is
limited.1
In the selection of the stent graft to be used, the
majority of studies did not report the percentage of over
sizing. In those studies reporting this parameter, an over
sizing of 10% to 15% was described, but it was not clear if
Fig 1. One-year patency of open versus enthis referred to the inner diameter or to the outer diameterof the artery.17,18,20,39 Antonello et al,3 however, used an
over sizing of 20% to 25%.
On average the diameter of the stents used was 9 mm 1
mm (range, 6 mm-14 mm) and the number of stents was 2
(range, 1-3),3,9,12,13,17-20,24,26-28,30,33,40,41 covering an average
lengthofarteryof110mm42mm.3,5,7,9-13,18-22,25,26,32,33,41
Patency rate
Analyses of the studies comparing open versus en-
dovascular repair. When comparing open versus endovas-
cular repair, there was no difference in primary patency rates at
one year (P  .46). The secondary patency rate appeared to
show a greater benefit for open repair, which did not reach
statistical significance using random effects model (P  .07;
Fig 1). Using a fixed effect model (analysis not shown), the
difference reached statistical significance, and in consideration
of the lack of statistical heterogeneity among the studies
included, this type of analysis may be credible.
At three years, there was no difference between the two
modalities of treatment (Fig 2).
Cumulative analyses of patency rates for endovas-
cular repair. The 30-day patency rate was 94% (95% CI
91%-97%), and although the studies were clinically heteroge-
neous, there was no statistical heterogeneity (I2  0; Fig 3).
The primary and secondary patency rate at 1 year were 83%
(95% CI, 79%-88%) and 86% (95% CI, 82%-91%), respec-
tively. A subgroup analysis of studies which used the He-
mobahn/Viabahn prostheses showed a not statistically signif-
icant greater patencywith these stentswhen comparedwith all
the others studies (primary patency, 89% [95% CI, 83%-94%]
vs 83% [95% CI, 78%-87%]; secondary patency 89% [95%
CI, 81%-96%] vs 86% [95% CI, 81%-90%]). A direct compar-
ison of Hemobahn/Viabahn prostheses alone versus all other
non-emobahn/Viabahn prostheses could not be done be-
cause many series used a variety of stents including He-
mobahn/Viabahn. The three-year primary and secondary pa-
tency rate was 74% (95% CI, 67%-81%) and 85% (95% CI,
78%-91%) (Figs 4 and 5). An analysis of the three-year patency
scular repair of popliteal artery aneurysms.using the Hemobahn/Viabahn prosthesis alone compared
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proved patency, although the difference did not achieve sta-
tistical difference (Figs 4 and 5).
Pharmacological adjuncts. In the majority of series,
double antiplatelet therapy (aspirin and ticlopidine or clopi-
dogrel) was used starting the day of surgery and continued for
a variable period of time from three months16 to life time.1
DISCUSSION
This review shows that when comparing open with
Fig 2. Three-year patency of open versus e
Fig 3. Thirty-day patency of all series of eendovascular repair, there was no difference in primarypatency rate at one year, with secondary patency rate
favoring open surgery at the limits of statistical signifi-
cance. There was no difference, however, in primary or
secondary patency rate at three years. This meta-analysis,
however, included only one small randomized, con-
trolled trial and three small cohort studies.
The pooled estimate of patency rate for endovascular
repair of PAA shows that primary and secondary patency
rates at one year are 83% and 86%; and at three years 74%
and 85%, respectively. These results are comparable with
ascular repair of popliteal artery aneurysms.
scular repair of popliteal artery aneurysms.that obtainable with open surgery: pooled estimates of
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The interpretations of the true role of endovascular repair
in the management of all clinical aspects of popliteal artery
aneurysms is, however, difficult since most series of endovas-
cular repair included asymptomatic patients with good ana-
tomic set up and good run-off. In addition, the approach to
the use of this new interventional strategy was not often
Fig 4. Three-year primary patency of all series of end
reporting the use of Hebobahn/Viabahn and non- Heb
Fig 5. Three-year secondary patency of all series of en
reporting the use of Hebobahn/Viabahn and non- Hebsystematic; different types of stents were used during the samestudy, and the criteria for the selection of the type of stent and
the diameter and the length were unclear.
A randomized, controlled trial is necessary to define the
true role of this new modality of treatment for popliteal
artery aneurysms. However, we can safely say that endovas-
cular repair in the presence of a suitable anatomy and with
good tibial run-off is not only feasible, but also safe and
with mid term results that are clinically acceptable and
ular repair of popliteal artery aneurysms, and of those
n/Viabahn prostheses.
cular repair of popliteal artery aneurysms, and of those
n/Viabahn prostheses.ovascdovasprobably not different from open repair.
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